Clinical Trial Update: Grass Pollen Subcutaneous Immunotherapy in Elderly Patients [Phase 4]

View source ↗

Summary

Phase 4 trial completed evaluating grass pollen subcutaneous immunotherapy in elderly patients with grass pollen allergy. The study focused on safety and effica…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Grass Pollen Allergy
• Seasonal Allergic Rhinitis

Drugs mentioned

• Grass pollen extract for subcutaneous immunotherapy (grass pollen extract)

Snippet

Sponsor: Medical University of Silesia | Conditions: Allergy | Phase 4 | Status: COMPLETED